Insulin prices fell for Medicare patients under Biden-era caps, study finds

Biden-era policies have reined in insulin prices for Medicare patients, a new study says. Roughly three out of four (75%) Medicare prescription beneficiaries were paying $35 or less for each month’s supply of insulin within a year of price caps enacted under President Joe Biden, researchers report in the Journal of the American Medical Association.

…